chromogenic in situ hybridization

GENETIC2 trials

Sponsors

SWOG Cancer Research Network, GERCOR - Multidisciplinary Oncology Cooperative Group

Conditions

Colorectal CancerLung Cancer

Phase 2

Panitumumab and Irinotecan as Third-Line Therapy in Treating Patients With Metastatic Colorectal Cancer

CompletedNCT00655499

GERCOR - Multidisciplinary Oncology Cooperative GroupColorectal Cancer

Start: 2008-06-30End: 2012-06-30Updated: 2021-09-21

Unknown Phase

S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer

CompletedNCT00450281

SWOG Cancer Research NetworkLung Cancer

Start: 2005-10-31End: 2012-07-31Updated: 2015-10-26

Related Papers

Panitumumab combined with irinotecan for patients with KRAS wild-type metastatic colorectal cancer refractory to standard chemotherapy: a GERCOR efficacy, tolerance, and translational molecular study.

2012-10-0563 citations